» Articles » PMID: 39272192

A Case of Basal Cell Carcinoma of Skin with Bone Metastasis: a Case Report

Overview
Journal J Med Case Rep
Publisher Biomed Central
Specialty General Medicine
Date 2024 Sep 13
PMID 39272192
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Basal cell carcinoma is the most prevalent skin cancer, most characterized by local aggressiveness but with low metastatic potential, and bone metastasis is quite heterogeneous, thus the incidence profile is variable size from 0.0028% to 0.5%. We have this patient with an unusual example of basal cell carcinoma with bone metastases to add to the scarce report on this matter.

Case Description: Here we document a 48-year-old Persian man with a background of being exposed to the sun for a long time. He was diagnosed with an ulcer on the cheek, which was clinically characterized and further confirmed by biopsy as morpheaform basal cell carcinoma. Following the first round of excision, multiple relapses eventually metastasized to the bone. The latter was found on follow-up radiologic scans. This case is characterized by the aggressive nature of the disease and the heterogeneity of basal cell carcinoma growth, thus challenging the conventional view of basal cell carcinoma behavior. Treatment included surgical excision of the primary lesion, which was treated with radiotherapy afterward. However, the skeleton improved slowly during follow-up, and palliative care was eventually pursued to control symptoms and improve quality of life.

Conclusions: This was a rare case of basal cell carcinoma metastasis to non-bone organs, which reminded us to consider basal cell carcinoma metastasis, especially in the case of atypical basal cell carcinoma. Therefore, risk-aware patient management is essential. Moreover, these findings highlight the role of further research into the mechanisms of basal cell carcinoma metastasis, leading to improved therapeutic strategies that may lead to potential improvements in patient outcomes.

Citing Articles

A Case of Pneumocephalus Due to an Untreated Atrial-Esophageal Fistula Post-Left Atrial Ablation Therapy.

Fatima E, Hill I, Fatima S, Akay M, Ratnani I Cureus. 2024; 16(11):e73538.

PMID: 39669825 PMC: 11636948. DOI: 10.7759/cureus.73538.

References
1.
Lear J . Oral hedgehog-pathway inhibitors for basal-cell carcinoma. N Engl J Med. 2012; 366(23):2225-6. DOI: 10.1056/NEJMe1202170. View

2.
Wu X, Elkin E, Marghoob A . Burden of basal cell carcinoma in USA. Future Oncol. 2015; 11(22):2967-74. DOI: 10.2217/fon.15.180. View

3.
Wollina U, Tchernev G . Advanced basal cell carcinoma. Wien Med Wochenschr. 2013; 163(15-16):347-53. DOI: 10.1007/s10354-013-0193-5. View

4.
Bakshi A, Chaudhary S, Rana M, Elmets C, Athar M . Basal cell carcinoma pathogenesis and therapy involving hedgehog signaling and beyond. Mol Carcinog. 2017; 56(12):2543-2557. PMC: 5962346. DOI: 10.1002/mc.22690. View

5.
Muzic J, Schmitt A, Wright A, Alniemi D, Zubair A, Olazagasti Lourido J . Incidence and Trends of Basal Cell Carcinoma and Cutaneous Squamous Cell Carcinoma: A Population-Based Study in Olmsted County, Minnesota, 2000 to 2010. Mayo Clin Proc. 2017; 92(6):890-898. PMC: 5535132. DOI: 10.1016/j.mayocp.2017.02.015. View